Le Lézard
Classified in: Health
Subject: LAW

B. Braun Obtains Preliminary Injunction Against Poly Medicure (Polymed) for Misleading Advertising


MELSUNGEN, Germany, November 21, 2017 /PRNewswire/ --

B. Braun Melsungen AG has successfully asserted claims for unfair competition against Indian based Poly Medicure Ltd. because of misleading advertising performed by Poly Medicure. In the advertising materials handed out at the MEDICA trade fair in Cologne, Poly Medicure designated certain claims/graphics with TM symbols without actually enjoying trademark protection or having filed respective trademark applications. Against this, B. Braun obtained a preliminary injunction at the Regional Court of Cologne (Docket No.: 33 O 181/17) on 15 November 2017 after Poly Medicure rejected B. Braun's claims. The preliminary injunction order was granted by the court without prior hearing while the court was aware of Poly Medicure's arguments put forward in their reply to B. Braun's warning letter. B. Braun enforced the preliminary injunction order directly at the MEDICA trade fair by having it served upon Poly Medicure through the bailiff. The decision is not final, yet.

Contact:
Franziska Hentschke
+49-5661-71-1635
[email protected]


These press releases may also interest you

at 11:04
MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...

at 11:00
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura,...

at 10:53
A one-of-a-kind healthcare collaborative, the Center for Better Aging (CBA) located at St. Bernard Hospital, opens in July with a health equity mandate to serve the growing 50+ population on Chicago's Greater South Side. ...

at 10:46
FullCare Medical has launched a new medical garment production facility in Tatu City, the 5,000-acre mixed-use Special Economic Zone (SEZ) in Kenya....

at 10:45
Moleculin Biotech, Inc., (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced Walter Klemp, President and Chief Executive Officer of...



News published on and distributed by: